logo
Property owners warned after council finds 'significant' invasive weed in Aussie garden

Property owners warned after council finds 'significant' invasive weed in Aussie garden

Yahooa day ago
A stern warning has been issued to Aussies after a 'vigilant' council worker stumbled upon a 'significant" invasive weed and several other prohibited species in a homeowner's garden.
A land protection officer for Bundaberg Regional Council was wandering near the property when they spotted three mature yellow fever trees — a potentially dangerous weed that is banned in Queensland over fears it could become a major pest.
The concerning sight prompted the council worker to alert authorities through the state's Weed Spotters Network, and on closer inspection by Biosecurity Queensland, additional prohibited species were also located in the yard.
In total, 31 problematic trees, along with thousands of seeds and seedlings, were removed and destroyed.
What are yellow fever trees?
Yellow fever trees are native to southern and eastern Africa, but like most of Australia's environmental weeds they were introduced to the country as ornamental plants. They can grow up to 25 metres tall and have a smooth bark coated in a greenish-yellow powder that can easily rub off. Its name is believed to reflect the bark and the plant's tendency to grow in swampy areas of Africa, where malaria is common.
While yellow fever trees have been found in gardens around the country, the species doesn't appear to have naturalised. However, due to concerns it could escape cultivation and spread, the Queensland government has deemed it a target for eradication.
A spokesperson for the state's Department of Primary Industries told Yahoo News yellow fever trees pose a 'similar weed risk to prickly acacia', which has invaded 'more than six million hectares' and is considered to be 'one of Queensland's most invasive weeds'.
Prickly acacia, a thorny shrub that can form dense thickets, currently costs the state's grazing industry $3 to $5 million a year.
🌱 Council's warning as backyard plant sprouts up in 'hectic' Aussie location
🪏 Aussies urged to dig up invasive plant that becomes 'very difficult to remove'
🍄 Cyclists' discovery in forest highlights growing Aussie issue: 'Prolific'
What other prohibited species were removed?
The spokesperson said three other 'suspected exotic acacia species' found on the property included paperbark thorn, monkey thorn and ana tree.
'The prohibited exotic acacia trees were mechanically removed and Biosecurity Queensland officers collected seed from the surrounding area,' they explained.
'Long-term surveillance on the infected property and surrounding area may be required to prevent germination of new plants and achieve eradication.'
Exotic acacia species are listed as prohibited under the Queensland Biosecurity Act 2014. All sightings of the species are required to be reported to Biosecurity Queensland on 13 25 23 within 24 hours.
The homeowner was not aware that the plants were banned and has been supportive of the eradication, the spokesperson said.
'Members of the community can help reduce the spread of exotic acacia species by reporting any suspect sightings and taking care not to move seeds or young plants,' they added.
Love Australia's weird and wonderful environment? 🐊🦘😳 Get our new newsletter showcasing the week's best stories.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

ASX Penny Stocks To Watch With Market Caps Under A$200M
ASX Penny Stocks To Watch With Market Caps Under A$200M

Yahoo

time11 minutes ago

  • Yahoo

ASX Penny Stocks To Watch With Market Caps Under A$200M

As the Australian market faces a challenging week with futures down and global tariff tensions looming, investors are keenly observing potential opportunities. Despite its somewhat outdated name, the concept of penny stocks remains relevant for those interested in smaller or newer companies that might offer substantial value. By focusing on firms with solid financial foundations and growth potential, investors can uncover hidden gems within this sector. Top 10 Penny Stocks In Australia Name Share Price Market Cap Financial Health Rating Alfabs Australia (ASX:AAL) A$0.40 A$114.64M ★★★★☆☆ EZZ Life Science Holdings (ASX:EZZ) A$2.03 A$95.76M ★★★★★★ GTN (ASX:GTN) A$0.57 A$108.68M ★★★★★★ IVE Group (ASX:IGL) A$2.95 A$454.84M ★★★★★☆ West African Resources (ASX:WAF) A$2.35 A$2.68B ★★★★★★ Southern Cross Electrical Engineering (ASX:SXE) A$1.775 A$469.33M ★★★★★★ Regal Partners (ASX:RPL) A$2.92 A$981.78M ★★★★★★ Sugar Terminals (NSX:SUG) A$0.99 A$360M ★★★★★★ Austco Healthcare (ASX:AHC) A$0.37 A$134.79M ★★★★★★ CTI Logistics (ASX:CLX) A$1.86 A$149.81M ★★★★☆☆ Click here to see the full list of 460 stocks from our ASX Penny Stocks screener. Here's a peek at a few of the choices from the screener. CleanSpace Holdings Simply Wall St Financial Health Rating: ★★★★★☆ Overview: CleanSpace Holdings Limited designs, manufactures, and sells respiratory protection products and services for healthcare and industrial markets globally, with a market cap of A$59.48 million. Operations: The company generates revenue of A$17.61 million from its respiratory products segment. Market Cap: A$59.48M CleanSpace Holdings, with a market cap of A$59.48 million, is navigating the challenges of being unprofitable while generating A$17.61 million in revenue from its respiratory products. Despite its negative return on equity and increasing losses over the past five years, it has managed to reduce its debt-to-equity ratio significantly from 51.9% to 14.8%. The company's short-term assets comfortably cover both short- and long-term liabilities, indicating financial stability in the near term. However, the management team lacks extensive experience with an average tenure of 1.9 years, which could impact strategic execution moving forward. Click to explore a detailed breakdown of our findings in CleanSpace Holdings' financial health report. Gain insights into CleanSpace Holdings' future direction by reviewing our growth report. Sandon Capital Investments Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Sandon Capital Investments Limited is a publicly owned investment manager with a market capitalization of A$129.27 million. Operations: The company's revenue is derived entirely from Investing Activities, totaling A$23.02 million. Market Cap: A$129.27M Sandon Capital Investments, with a market cap of A$129.27 million, shows financial resilience as its short-term assets (A$167.4M) exceed both short- and long-term liabilities. The company's net profit margins have improved to 70.7%, although it faced negative earnings growth over the past year, contrasting with the industry average growth of 23.4%. Its debt is not well covered by operating cash flow but remains manageable due to more cash than total debt and strong interest coverage by EBIT (9.1x). Despite a low return on equity at 12.6%, its price-to-earnings ratio suggests it may be undervalued compared to the broader Australian market. Dive into the specifics of Sandon Capital Investments here with our thorough balance sheet health report. Explore historical data to track Sandon Capital Investments' performance over time in our past results report. Shaver Shop Group Simply Wall St Financial Health Rating: ★★★★★★ Overview: Shaver Shop Group Limited operates as a retailer of personal care and grooming products in Australia and New Zealand, with a market cap of A$193.90 million. Operations: The company's revenue is primarily generated through retail store sales of specialist personal grooming products, amounting to A$218.14 million. Market Cap: A$193.9M Shaver Shop Group Limited, with a market cap of A$193.90 million, operates debt-free and demonstrates financial stability as its short-term assets (A$62.1M) exceed both short- and long-term liabilities. The company has experienced negative earnings growth over the past year (-6.1%), yet forecasts suggest a 7.96% annual growth in earnings moving forward. Despite a decline in net profit margins from 7.1% to 6.7%, Shaver Shop's seasoned management team and high-quality past earnings contribute to its resilience in the market, trading at 54.3% below estimated fair value without significant shareholder dilution recently observed. Click here to discover the nuances of Shaver Shop Group with our detailed analytical financial health report. Evaluate Shaver Shop Group's prospects by accessing our earnings growth report. Summing It All Up Click here to access our complete index of 460 ASX Penny Stocks. Ready For A Different Approach? This technology could replace computers: discover the 26 stocks are working to make quantum computing a reality. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:CSX ASX:SNC and ASX:SSG. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio

Alarm raised after strange backyard phenomenon worsens in Aussie region
Alarm raised after strange backyard phenomenon worsens in Aussie region

Yahoo

time2 hours ago

  • Yahoo

Alarm raised after strange backyard phenomenon worsens in Aussie region

For the last two decades, a strange backyard phenomenon has been noticed by alarmed residents in northern Australia. The frogs in their towns have been presenting with strange growths that resemble cancer, and because tumours are rare in frogs there have been increasing concerns about chemical contamination and emerging disease. On Friday, scientists from the University of Queensland announced they would begin investigating the problem, noting it was important to determine whether the tumours were being caused by something that could also impact human health. Dr Viviana Gonzalez-Astudillo from the School of Veterinary Science explained that frogs can get similar types of cancers to humans. And because they breathe and absorb water through their skin, they're a good bio-indicator of any contaminants in the environment. 'Because frogs have such an intimate relationship with our waterways, anything we put out there in the form of chemicals or pathogens — viruses, fungi, parasites or bacteria — they're going to be probably the first type of vertebrate that is going to be exposed and manifest something,' she told Yahoo News Australia. 'That is where the concern is, and that is why we need to investigate.' Related: Mutant turtles discovered in contaminated Aussie waterways Chemical contamination found in one-third of frogs Dr Gonzalez-Astudillo said the investigation should not cause 'wide-scale panic' about new contaminants entering the environment, and it's important to stress the cause of the growths remains a mystery. But there are pervasive substances like PFAS, which is commonly used in non-stick cookware and flame retardants, or even long-banned chemicals that can exist in the environment for decades, and it's important to rule this out. Chemical contamination is a known problem affecting frogs. An Australian Museum and University of NSW study published in April found 36 per cent of frogs in eastern NSW had either a rodenticide or legacy pesticide in their livers. But frogs are also highly susceptible to disease — the introduction of chytrid fungus caused at least six extinctions in Australia. Clusters of the mystery tumours have been restricted to towns around Far North Queensland, and since 1998, non-profit group Frog Safe has assessed 60 animals. Last year, Yahoo reported that since 2020, four new forms of the disease had emerged that hadn't been encountered before. Because the tumours are generally found around the eyes and mouth, without medical attention, vital bodily functions are inhibited, and the frogs die. Herpes virus linked to separate disease cluster In Queensland, the tumours have been found in white-lipped and common green tree frogs. Similar symptoms have been documented in the North American leopard frog, where the problem was linked to a frog herpes virus that develops when the weather is hotter. Anecdotally, the mystery frog tumours in Queensland are becoming more prevalent, but this now needs to be backed up by scientific evidence. It's rare for vets to treat sick frogs, so it's believed most cases go unreported. Plan to revive frog sound not heard since 1980s in Canberra Incredible Australian footage reveals native predator killing city rats Warning 'nowhere is safe' as Australia's 500km toxic problem spreads For the research to be successful, the University of Queensland team need public help. They're calling on anyone who spots a frog with an unusual growth to contact Frog Safe on (07) 4006 3784 and email the photos to sickfrog@ Attempts will be made to treat all sick frogs, and no animals will be killed specifically for the study. The research is expected to run until November, 2026 and is supported by the CSIRO Ecosurveillance Systems team. Love Australia's weird and wonderful environment? 🐊🦘😳 Get our new newsletter showcasing the week's best stories.

VB Spine Launches in Australia and New Zealand
VB Spine Launches in Australia and New Zealand

Yahoo

time6 hours ago

  • Yahoo

VB Spine Launches in Australia and New Zealand

Stryker's spinal implants business in Australia and New Zealand fully transitions to VB Spine and LifeHealthcare continues as exclusive distributor NEW YORK & SYDNEY, July 31, 2025--(BUSINESS WIRE)--VB Spine LLC ("VB Spine"), a global, family-led spine company dedicated to advancing patient outcomes, announced the completion of the sale of Stryker's spinal implants business in Australia and New Zealand. This milestone builds upon the formation of VB Spine on April 1, 2025, following the acquisition of Stryker's U.S. spinal implants business by Viscogliosi Brothers, LLC. It also marks VB Spine's first market entry outside the United States and establishes a direct presence in two fast-growing markets. VB Spine continues to have exclusive access to Stryker's Mako Spine and the Copilot automatic depth stop feature. This strategic partnership creates a strong foundation for VB Spine's continued growth, providing surgeons greater precision and improving patient outcomes. "From the start, our vision has been simple: put patients first and innovate boldly," said Marc Viscogliosi, co-CEO of VB Spine, speaking for his brothers and fellow co-CEOs Anthony and John Viscogliosi. "Today we take that vision global. By combining the passion of our family-run culture with LifeHealthcare's best-in-class surgeon support, we're opening a new chapter in spine care defined by access, outcomes, and possibility." LifeHealthcare, already the long-standing distributor for these products, will continue as the exclusive partner, providing uninterrupted product availability and clinical support for surgeons and their patients throughout Australia and New Zealand. Paul Petherbridge, CEO of LifeHealthcare, said, "We are pleased to announce our long-term collaboration with VB Spine. LifeHealthcare has represented this portfolio since 2010, providing clinicians and patients in Australia and New Zealand with reliable access to spinal instrumentation and implants through our experienced team. Our partnership with VB Spine aligns with our mission for Spine in ANZ: 'What matters to you drives us.' We look forward to working with the Viscogliosi brothers and the VB Spine team to offer innovative solutions and valuable education to our clinicians." Transition highlights All current spinal implant SKUs remain available through LifeHealthcare with no service interruption. Surgeons and hospitals will continue to work with their local LifeHealthcare representatives. VB Spine plans to attend Deformity Down Under (DDU) in Brisbane, which began as a surgeon-led initiative to foster collaboration, share knowledge, and improve outcomes in spine surgery. Forward-looking statements Certain statements in this release are forward-looking and are based on current expectations, forecasts, and assumptions. Actual results may differ materially due to regulatory, commercial, and operational risks. VB Spine disclaims any obligation to update forward-looking statements except as required by law. Transaction financing Viscogliosi Brothers, LLC and Viscogliosi Brothers Watermark Holdings LLC are equity investors in VB Spine. About VB Spine VB Spine LLC is the largest privately held spine company and among the largest family-owned medical technology companies in the world. With a comprehensive product portfolio and a large and growing global distribution network, VB Spine delivers specialized solutions that address critical needs in spine surgery and enhance patient outcomes. Focused on people, partnerships and operational excellence, VB Spine ensures healthcare professionals have access to the tools and resources needed to provide the highest standard of care. VB Spine is owned and led by the Viscogliosi Brothers. For more information on VB Spine, please visit About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at About LifeHealthcare Distribution Pty Ltd (Australia) and LifeHealthcare Ltd (New Zealand) LifeHealthcare, an EBOS MedTech company, is committed to providing patients in Australia and New Zealand with access to world-class medical devices and technology. Our goal is to ensure the long-term economic sustainability of the healthcare system. We offer a diverse range of products across various channels for surgical intervention, including but not limited to therapeutic areas such as Spine and Enabling Technology, Orthopaedics (Reconstruction, Extremities, and Regenerative Medicine), Plastics and Reconstructive Surgery, Neurovascular Intervention, Abdo-Pelvic Surgery, and Neurosurgery, among others. For more information about LifeHealthcare, please visit or About Viscogliosi Brothers Viscogliosi Brothers, LLC is a family-owned New York City-based family office dedicated to driving growth and innovation in the neuro-musculoskeletal industry. Established in 1999, the firm focuses on identifying and building groundbreaking innovations in healthcare, aiming to address unmet clinical needs, enhance patient outcomes, and drive cost efficiency in the healthcare system. Since its inception 26 years ago, Viscogliosi Brothers has founded, financed, operated and grown 43 businesses with operations and distribution across more than 80 countries. These businesses have positively impacted millions of patients with cutting-edge innovations in healthcare. The firm has led the transformation of the spine industry through its multiple businesses specifically including: Spine Solutions, Spine Next, Paradigm Spine, Simplify Medical, Centinel Spine, Companion Spine, Spine BioPharma and Woven Orthopedic Technologies, among others. For more information, visit About Viscogliosi Brothers Watermark Viscogliosi Brothers Watermark LLC is a New York City-based holding company specializing in investing in innovation within the MedTech sector. Founded in 2022, VBW is committed to creating alternative wealth for its shareholders while enhancing humanity's well-being. With a portfolio-driven investment mandate and strategic expertise, VBW supports its invested entities through financing and manufacturing capabilities. For more information, visit View source version on Contacts For media inquiries only: vbspinecommunications@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store